CRSP
CRISPR Therapeutics AG · Healthcare
48.60
1.12%(-0.55)
Market OpenLast Updated: — ET
52W L: $30.5252W H: $78.48
$48.44
CHG-6.16 (-11.28%)
H$59.85
L$44.00
VOL41M
CRSP (1h)
CRISPR Therapeutics AG · Healthcare
ZUG, Switzerland and BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, Apr 13 at 2:15 p.m. ET. A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events.
CRISPR Therapeutics is the second largest holding in Cathie Wood's Ark Innovation ETF. Incoming clinical trial data could send the stock soaring this year.
What if the biggest winners in biotech weren't the ones promising miracle cures, but the ones quietly supplying the picks and shovels — data that makes those cures possible?
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $49.51, moving +1.43% from the previous trading session.
In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $48.81, denoting a +2.61% move from the preceding trading day.
CRISPR Therapeutics AG (CRSP) is rated Buy, with a 12-month price target of $64.58, driven by CASGEVY's commercial ramp and a robust pipeline. CASGEVY's increasing patient initiations and revenue growth provide a near-term path to profitability, with a strong foundation for future expansion. CRSP's in vivo cardiovascular pipeline, notably CTX310 and CTX320/321, targets large, underserved markets with disruptive one-time gene therapies.
KASINGER JAMES R.
officer: General Counsel and Secretary
6,250 SH @ $0.00
2026-03-20
KASINGER JAMES R.
officer: General Counsel and Secretary
3,182 SH @ $46.78
2026-03-23
KASINGER JAMES R.
officer: General Counsel and Secretary
38,499 SH @ $46.24
2026-03-20
KASINGER JAMES R.
officer: General Counsel and Secretary
25,000 SH @ $0.00
2026-03-20
KASINGER JAMES R.
officer: General Counsel and Secretary
6,250 SH @ $0.00
2026-03-20
Kulkarni Samarth
director, officer: Chief Executive Officer
19,687 SH @ $0.00
2026-03-20
Kulkarni Samarth
director, officer: Chief Executive Officer
10,020 SH @ $46.78
2026-03-23
Kulkarni Samarth
director, officer: Chief Executive Officer
114,249 SH @ $46.24
2026-03-20